A biologically competitive 21 days hypofractionation scheme with weekly concomitant boost in breast cancer radiotherapy feasibility acute sub-acute and short term late effects

Radiation Oncology

Volumn 5, Issue 1, 2010, Pages

  Guenzi, Marina ^a   Vagge, Stefano ^a   Azinwi, Ngwa C ^a   D'Alonzo, Alessia ^a   Belgioia, Liliana ^a   Garelli, Stefania ^a   Gusinu, Marco ^a   Corvò, Renzo ^a,b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RADIOTHERAPY; FEMALE; FIBROSIS; FOLLOW UP; HUMAN; HYPERPIGMENTATION; IRRADIATION; MAJOR CLINICAL STUDY; PARTIAL MASTECTOMY; PROSPECTIVE STUDY; TOXICITY; ADJUVANT THERAPY; BREAST TUMOR; CLINICAL TRIAL; FEASIBILITY STUDY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PAGET NIPPLE DISEASE; PATHOLOGY; RADIATION DOSE; RADIATION DOSE FRACTIONATION; SEGMENTAL MASTECTOMY; TIME; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; TIME FACTORS; TREATMENT OUTCOME;

EID: 78549236869     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-5-111     Document Type: Article

References (24)

1. Freedman GM, Andersson PR, Goldstein LJ, Ma CM, Li J, Swaby RF, Litwin S, Watkins-Bruner D, Sigurdson ER, Morrow M. Four-week course of radiation for breast cancer using hypofractionated intensity modulated radiation therapy with an incorporated boost. Int J Radiat Oncol Biol Phys 2007, 68(2):347-53. 10.1016/j.ijrobp.2006.12.035, 17379430.
2. Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E, Godwin J, Gray R, Hicks C, James S, MacKinnon E, McGale P, McHugh T, Peto R, Taylor C, Wang Y, . Early Breast Cancer Trialists' Collaborative Group (EBCTCG) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials. Lancet 2005, 366:2087-2106. Early Breast Cancer Trialists' Collaborative Group (EBCTCG).
3. Ash DV, Benson EA, Sainsbury JR, Round C, Head C. Seven-year follow-up on 334 patients treated by breast conserving surgery and short course radical postoperative radiotherapy: a report of the Yorkshire Breast Cancer Group. Clin Oncol (R Coll Radiol) 1995, 7(2):93-6.
4. Olivotto IA, Weir LM, Kim-Sing C, Bajdik CD, Trevisan CH, Doll CM, Lam WY, Basco VE, Jackson SM. Late cosmetic results of short fractionation for breast conservation. Radiother Oncol 1996, 41(1):7-13. 10.1016/S0167-8140(96)91824-1, 8961362.
5. Shelley W, Brundage M, Hayter C, Paszat L, Zhou S, Mackillop W. A shorter fractionation schedule for postlumpectomy breast cancer patients. Int J Radiat Oncol Biol Phys 2000, 47(5):1219-28. 10.1016/S0360-3016(00)00567-8, 10889375.
6. Bentzen SM, Agrawal RK, Aird EG, Barrett JM, Barrett-Lee PJ, Bliss JM, Brown J, Dewar JA, Dobbs HJ, Haviland JS, Hoskin PJ, Hopwood P, Lawton PA, Magee BJ, Mills J, Morgan DA, Owen JR, Simmons S, Sumo G, Sydenham MA, Venables K, Yarnold JR. START Trialists' Group The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol 2008, 9(4):331-41. 10.1016/S1470-2045(08)70077-9, 2323709, 18356109, START Trialists' Group.
7. Bentzen SM, Agrawal RK, Aird EG, Barrett JM, Barrett-Lee PJ, Bentzen SM, Bliss JM, Brown J, Dewar JA, Dobbs HJ, Haviland JS, Hoskin PJ, Hopwood P, Lawton PA, Magee BJ, Mills J, Morgan DA, Owen JR, Simmons S, Sumo G, Sydenham MA, Venables K, Yarnold JR. START Trialists' Group The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet 2008, 371(9618):1098-107. 10.1016/S0140-6736(08)60348-7, 2277488, 18355913, START Trialists' Group.
8. Whelan T, Pignol J, Levine M, Julian J, MacKenzie R, Parpia S, Shelley W, Grimard L, Bowen J, Lukka H, Perera F, Fyles A, Schneider K, Gulavita S, Freeman C. Long-Term Results of Hypofractionated Radiation Therapy for Breast Cancer. N Engl J Med 2010, 362:513-20. 10.1056/NEJMoa0906260, 20147717.
9. Guerrero M, Li XA, Earl MA, Sarfaraz M, Kiggundu E. Simultaneous integrated boost for breast cancer using IMRT: a radiobiological and treatment planning study. Int J Radiat Oncol Biol Phys 2004, 59(5):1513-22. 10.1016/j.ijrobp.2004.04.007, 15275739.
10. Van der Laan HP, Dolsma WV, Maduro JH, Korevaar EW, Hollander M, Langendijk JA. Three-dimensional conformal simultaneously integrated boost technique for breast-conserving radiotherapy. Int J Radiat Oncol Biol Phys 2007, 68(4):1018-23. 10.1016/j.ijrobp.2007.01.037, 17379440.
11. Jalali R, Malde R, Bhutani R, Budrukkar A, Badwe R, Sarin R. Prospective evaluation of concomitant tumour bed boost with whole breast irradiation in patients with locally advanced breast cancer undergoing breast-conserving therapy. Breast 2008, 17(1):64-70. 10.1016/j.breast.2007.07.033, 17851077.
12. Corvò R, Giudici S, Maggio F, Bevegni M, Sampietro C, Lucido MR, Orsatti M. Weekly concomitant boost in adjuvant radiotherapy for patients with early breast cancer: preliminary results on feasibility. Tumori 2008, 94(5):706-11.
13. Primary Therapy of Early Breast Cancer; 9th International Conference, January, 26-29, 2005. Breast 2005, 14(suppl 1):S1-56. St Gallen, Switzerland.
14. Joiner MC, van der Kogel AJ. The linear-quadratic approach to fractionation and calculation of isoeffect relationships. Basic Clinical Radiobiology 1997, 106-122. Arnold, London, Steel GG, 2nd.
15. Owen JR, Ashton A, Bliss, Homewood J, Harper C, Hanson J, Haviland J, Bentzen SM, Yarnold JR. Effect of radiotherapy fraction size on tumour control in patients with early stage breast cancer after local tumour excision. Long-term results of a randomized trial. Lancet Oncol 2006, 7:467-471. 10.1016/S1470-2045(06)70699-4, 16750496.
16. Herrmann T, Baumann M, Dörr W. Klinische stahlenbiologie - kurz und bündig, 4th end 2006, Munich: Elsevier.
17. Bentzen SM, Overgaard M. Relationship between early and late normal-tissue injury after postmastectomy radiotherapy. Radiother Oncol 1991, 20(3):159-65. 10.1016/0167-8140(91)90092-U, 1852907.
18. Gaya AM, Ashford RFU. Cardiac Complications of Radiation Therapy. Clinical Oncology 2005, 17:153-159. 10.1016/j.clon.2004.09.016, 15900998.
19. Radiation Therapy Oncology Group Acute Radiation Morbidity Scoring Criteria. Radiation Therapy Oncology Group., http://www.rtog.org/members/toxicity/acute.html
20. LENT/Soma Tables Radiat Oncol 1995, 35:17-60.
21. Fowler JF. The linear-quadratic formula and progress in fractionated radiotherapy. Br j Radiol 1989, 62:679-694. 10.1259/0007-1285-62-740-679, 2670032.
22. Fujii O, Hiratsuka J, Nagase N, Tokiya R, Yoden E, Sonoo H, Murashima N, Iha S, Imajyo Y. Whole-breast radiotherapy with shorter fractionation schedules following breast-conserving surgery: short-term morbidity and preliminary outcomes. Breast Cancer 2008, 15(1):86-92. 10.1007/s12282-007-0010-3, 18224401.
23. Livi L, Stefanacci M, Scoccianti S, Dicosmo D, Borghesi S, Nosi F, Simontacchi G, Mangoni M, Paiar F, Ponticelli P, Nori J, Chiavacci A, Biti GP. Adjuvant hypofractionated radiation therapy for breast cancer after conserving surgery. Clin Oncol (R Coll Radiol) 2007, 19(2):120-4.
24. Fajardo LF, Berthrong M, Anderson RE. Radiation pathology. 2001, New York: Oxford University Press.